Blocking of EGFR signaling by inhibitors like cetuximab activates the PI3K/Akt/mTOR pathway, which is regulated by PTEN (Phosphatase and tensin homolog), a tumor suppressor gene. This evidence concerns the gene EGFR and neoplasm.